The Effect of Probiotics ATG-F4 in Cancer Patients

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions

Pancreatic CancerColon Cancer

Interventions

DRUG

LT-002 (Lactobacillus reuteri ATG-F4

The group that will be consuming probiotics for 12 weeks.

Trial Locations (1)

RECRUITING

Chungnam National University Hospital, Daejeon

All Listed Sponsors

collaborator

AtoGen Co. Ltd

INDUSTRY

lead

Chungnam National University Hospital

OTHER